Optometry News

CHICAGO — In this Healio Video Perspective from Eyecelerator@AAO, Rob Sambursky, MD, president of Verséa Ophthalmics, discusses the company’s offerings for ocular wound healing and ocular surface diseases.

CHICAGO — In this Healio Video Perspective from Eyecelerator@AAO, Patrick Mooney, CEO of Spyglass Pharma, discusses the company’s IOL-based bimatoprost drug delivery platform for patients with open-angle glaucoma or ocular hypertension.

CHICAGO — Thanks to recent technological improvements, the ICL could take the place at the forefront of vision correction in the near future, according to a speaker here.

Post-refractive ectasia occurs very rarely, in only about one out of every 10,000 cases of refractive surgery, or 0.09% of LASIK procedures, 0.02% of PRK procedures and 0.01% of SMILE procedures, according to Moshirfar and colleagues.

CHICAGO — Collaborations and consolidations within the eye care space will be potentially disruptive over the next 5 years, according to a market expert at Eyecelerator@AAO.

CHICAGO — In this Healio Video Perspective from Eyecelerator@AAO, Greg Kunst of Aurion Biotech provides an update on the company’s cell therapy for corneal endothelial disease.

CHICAGO — In this Healio Video Perspective from Eyecelerator@AAO, Alex Lopez of Ace Vision Group discusses laser scleral microporation for presbyopia.

CHICAGO — In this Healio Video Perspective from Eyecelerator@AAO, Richard Small, CEO of Neurotech Pharmaceuticals, provides a company update ahead of the American Academy of Ophthalmology Meeting.

CHICAGO — In this Healio Video Perspective from Eyecelerator@AAO, Anthony Wallace of Bausch + Lomb provides an update on the latest happenings at the company.

Ryzumvi effectively reduced pharmacologically induced mydriasis within 60 to 90 minutes compared with placebo, while also exhibiting a favorable safety profile, according to results from two studies published in Ophthalmology.